mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.005 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.007 |